Reconstruction of the evolutionary dynamics of the hepatitis C virus 1b epidemic in Turkey

Infection, Genetics and Evolution

Volumn 11, Issue 5, 2011, Pages 863-868

  Ciccozzi, Massimo ^a   Ciccaglione, Anna Rita ^a   Presti, Alessandra Lo ^a   Yalcinkaya, Tulay ^b   Taskan, Zeynep Pinar ^b   Equestre, Michele ^a   Costantino, Angela ^a   Bruni, Roberto ^a   Ebranati, Erica ^c   Salemi, Marco ^d   Gray, Rebecca ^d   Rezza, Giovanni ^a   Galli, Massimo ^c   Zehender, Gianguglielmo ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Refik Saydam National Public Health Agency   (Turkey)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

HCV; Phylodynamics; Phylogeny; Phylogeography

Indexed keywords

NONSTRUCTURAL PROTEIN 5B;

ARTICLE; BAYES THEOREM; BLOOD TRANSFUSION; CLINICAL PRACTICE; CONTROLLED STUDY; CYPRUS; DRUG DEPENDENCE; EPIDEMIC; EVOLUTIONARY RATE; GENE SEQUENCE; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HUMAN; MOLECULAR EVOLUTION; MONOPHYLY; NONHUMAN; NS5B GENE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PHYLOGEOGRAPHY; POPULATION DYNAMICS; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TURKEY (REPUBLIC); VIRUS GENE; VIRUS STRAIN; VIRUS TRANSMISSION;

BAYES THEOREM; BIOLOGICAL EVOLUTION; EPIDEMICS; HEPACIVIRUS; HEPATITIS C; LIKELIHOOD FUNCTIONS; PHYLOGENY; PHYLOGEOGRAPHY; TIME FACTORS; TURKEY;

HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1;

EID: 79956305415     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2011.02.006     Document Type: Article

References (34)

1. Abacioglu Y.H., Davidson F., Tuncer S., Yap P.L., Ustacelebi S., Yulug N., Simmonds P. The distribution of hepatitis C virus genotypes in Turkish patients. J. Viral Hepat. 1995, 2:297-301.
2. Acar A., Kemahli S., Altunay H., Kosan E., Oncul O., Gorenek L., Cavuslu S. HBV, HCV and HIV seroprevalence among blood donors in Istanbul, Turkey: how effective are the changes in the national blood transfusion policies?. Braz. J. Infect. Dis. 2010, 14(1):41-46.
3. Bozdayi A.M., Aslan N., Bozdayi G., Türkyilmaz A.R., Sengezer T., Wend U., Erkan O., Aydemir F., Zakirhodjaev S., Orucov S., Bozkaya H., Gerlich W., Karayalçin S., Yurdaydin C., Uzunalimoĝlu O. Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients. Arch. Virol. 2004, 149:2115-2129.
4. Drummond A.J., Rambaut A., Shapiro B., Pybus O.G. Bayesian coalescent inference of past population dynamics from molecular sequences. Mol. Biol. Evol. 2005, 22:1185-1192.
5. Drummond A.J, Rambaut A BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 2007, 7:214.
6. Grenfell B.T., Pybus O.G., Gog J.R., Wood J.L., Daly J.M., Mumford J.A., Holmes E.C. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 2004, 303(5656):327-332.
7. Gurol E., Saban C., Oral O., Cigdem A., Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur. J. Epidemiol. 2006, 21:299-305.
8. Hall T.A. Bioedit: a user-friendly biological sequence alignment, editor and analysis program for Windows 95/98 NT. Nucl. Acids Symp. Ser. 1999, 41:95-98.
9. Hauri A.M., Armstrong G.L., Hutin Y.J. The global burden of disease attributable to contaminated injections given in health care settings. Int. J. STD AIDS 2004, 15(January (1)):7-16.
10. Hoofnagle J.H. Hepatitis C: the clinical spectrum of disease. Hepatology 1997, 26:15S-20S.
11. International Committee of the Red Cross Report, 2005. http://www.icrc.org/web/Eng/siteeng0.nsf/html/5GKE3D.
12. Kass R., Raftey A. Bayes factors. J. Am. Stat. Assoc. 1995, 90:773.
13. Kendrick D.B. Hospital center merger in Europe designed for better patient care. Mil. Med. 1964, 129(March):230-234.
14. Kocak N., Hepgul S., Ozbayburtlu S., Altunay H., Ozsoy M.F., Kosan E., Aksu Y., Yilmaz G., Pahsa A. Trends in major transfusion-transmissible infections among blood donors over 17 years in Istanbul, Turkey. J. Int. Med. Res. 2004, 32(6):671-675.
15. Lauer G.M., Walker B.D. Hepatitis C virus infection. N. Engl. J. Med. 2001, 345:41-52.
16. Lemey P., Rambaut A., Drummond A.J., Suchard M.A. Bayesian phylogeography finds its roots. PLoS Comput. Biol. 2009, 5:1-16.
17. Lu L., Nakano T., He Y., Fu Y., Hagedorn C.H., Robertson B.H. Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J. Med. Virol. 2005, 75:538-549.
18. Magiorkinis G., Magiorkinis E., Paraskevis D., Ho S.Y., Shapiro B., Pybus O.G., Allain J.P., Hatzakis A. The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med. 2009, 6(12):e1000198.
19. Ozsoy M.F., Oncul O., Cavuslu S., Erdemoglu A., Emekdas G., Pahsa A. Seroprevalences of hepatitis B and C among health care workers in Turkey. J. Viral Hepat. 2003, 10:150-156.
20. Posada D., Buckley T.R. Model selection and model averaging in phylogenetics: advantages of Akaike information criterion and Bayesian approaches over likelihood ratio tests. Syst. Biol. 2004, 53:793-808.
21. Power J.P., Lawlor E., Davidson F., Holmes E.C., Yap P.L., Simmonds P. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995, 345(8959):1211-1213.
22. Pybus O.G., Charleston M.A., Gupta S., Rambaut A., Holmes E.C., Harvey P.H. The epidemic behaviour of the hepatitis C virus. Science 2001, 292:2323-2325.
23. Pybus O.G., Cochrane A., Holmes E.C., Simmonds P. The hepatitis C virus epidemic among drug users. Infect. Genet. Evol. 2005, 5:131-139.
24. Pybus O.G., Markov P.V., Wu A., Tatem A.J. Investigating the endemic transmission of the hepatitis C virus. Int. J. Parasitol. 2007, 37:839-849.
25. Pybus O.G., Barnes E., Taggart R., Lemey P., Markov P.V., Rasachak B., Syhavong B., Phetsouvanah R., Sheridan I., Humphreys I.S., Lu L., Newton P.N., Klenerman P. Genetic history of hepatitis C virus in East Asia. J. Virol. 2009, 83:1071-1082.
26. Ramia S., Eid-Fares J. Distribution of hepatitis C virus genotypes in the Middle East. Int. J. Infect. Dis. 2006, 10:272-277.
27. Salemi M., Vandamme A.M. Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences. J. Mol. Evol. 2002, 54(1):62-70.
28. Schmidt H.A., Strimmer K., Vingron M., von Haeseler A., et al. TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing. Bioinformatics 2002, 18:502-504.
29. Selcuk H., Kanbay M., Korkmaz M., Gur G., Akcay A., Arslan H., Ozdemir N., Yilmaz U., Boyacioglu S. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment. Dig. Dis. Sci. 2006, 51:1420-1425.
30. Simmonds P. Genetic diversity and evolution of hepatitis C virus-15 years on. J. Gen. Virol. 2004, 85:3173-3188.
31. Simmonds P., et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005, 42:962-973.
32. Tanaka Y., Hanada K., Mizokami M., Yeo A.E., Shih J.W., Gojobori T., Alter H.J. Inaugural article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc. Natl. Acad. Sci. U.S.A. 2002, 99(24):15584-15589.
33. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., Higgins D.G. CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1994, 25:4876-4882.
34. World Health Organization Hepatitis C-global prevalence (update). Wkly. Epidemiol. Rec. 1999, 49:425-427.